Please complete the CAPTCHA to continue
@gripcurrent.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Josh Thornton is listed as Talent Acquisition Consultant at Biomind Talent at Biomind Talent, based in Haleiwa, Hawaii, United States. AeroLeads shows a work email signal at gripcurrent.com and a matched LinkedIn profile for Josh Thornton.
Josh Thornton previously worked as Talent Acquisition Consultant, CFO at Biomind Talent and Senior Recruitment Consultant at Spyre Therapeutics. Josh Thornton holds Bachelor Of Science (B.S.), Business, Management, Marketing, And Related Support Services from West Chester University Of Pennsylvania.
This section adds company-level context without repeating Josh Thornton's masked contact details.
AeroLeads found 1 current-domain work email signal for Josh Thornton. Compare company email patterns before reaching out.
Biotech/Pharma Recruitment Consultant helping both small and large organizations source diverse candidates to meet their growing workforce opportunities. Let's connect, send me a LinkedIn invitation today or contact me at biomindtalent@gmail.com I am currently focusing on networking and building talent pipelines for the following functions:- R&D (Research, Clinical Operations, Clinical Development, Biometrics, Drug Safety, Regulatory Affairs)
Listed skills include Inbound Marketing, Seo, Link Building, Web Development, and 1 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Recruitment Consultant supporting the Biotech/Pharma industry. A managing member of Biomind Talent's Acquisition team. Actively identifies, assesses, networks and pipelines diverse talent for various Research & Development opportunities.
San Francisco, Ca, Us
Spyre Therapeutics is developing potential best-in-class antibodies, rational therapeutic combinations, and precision immunology approaches with the goal of creating Inflammatory Bowel Disease (IBD) therapies with uncompromising efficacy and convenience.
Eindhoven, North Brabant, Nl
With founders who are global leaders in the structural biology of 14-3-3 proteins and their role in a wide range of protein-protein interactions, our team is developing a new class of medicines that can modulate previously undruggable targets and influence currently accessible ones in new ways. These small molecule stabilizers of 14-3-3:client complexes have the potential to address serious unmet needs in important therapeutic areas including cancer, metabolic disorders, neurodegenerative and infectious diseases.Our company is committed to aggressively expanding the boundaries of medicine through treatments that modulate some of the most challenging and potentially impactful targets identified across the proteome, with the goal of treating diseases that currently lack a cure and helping patients live longer and healthier lives.
Irvine, California, Us
Reneo is a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic diseases including mitochondrial diseases with significant unmet medical needs.Reneo is initially developing mavodelpar (REN001) in two rare genetic diseases that typically present with myopathy: primary mitochondrial myopathies (PMM), and long-chain fatty acid oxidation disorders (LC-FAOD).Reneo has completed a Phase 1b clinical trial in patients with PMM and are currently enrolling patients in a global Phase 2b clinical trial (STRIDE Study). In addition, we conducted two exploratory Phase 1b clinical trials of mavodelpar in patients with LC-FAOD and McArdle disease, respectively.
Bothell, Washington, Us
Seagen is a global biotechnology company that develops and commercializes transformative cancer therapies. We’re driven by a singular mission—to make a difference for people impacted by cancer.As an industry leader in antibody–drug conjugate (ADC) technology, we pioneered the science of harnessing antibodies to deliver cell-killing agents directly to cancer cells. This technology is the foundation of two of our approved medicines—ADCETRIS® (brentuximab vedotin) and PADCEV® (enfortumab vedotin-ejfv).Today, our research efforts are focused on advancing a pipeline of novel targeted therapies, including TUKYSA® (tucatinib), recently approved for certain metastatic HER2+ breast cancers. We’re also leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents.
Ran a full general contracting business and sub-contracted with partnering companies. Also owned a Home Inspection company.
Quick answers generated from the profile data available on this page.
Josh Thornton works for Biomind Talent.
Josh Thornton is listed as Talent Acquisition Consultant at Biomind Talent at Biomind Talent.
AeroLeads has found 1 work email signal at @gripcurrent.com for Josh Thornton at Biomind Talent.
Josh Thornton is based in Haleiwa, Hawaii, United States while working with Biomind Talent.
Josh Thornton has worked for Biomind Talent, Spyre Therapeutics, Ambagon Therapeutics, Reneo Pharmaceuticals, and Seagen.
You can use AeroLeads to view verified contact signals for Josh Thornton at Biomind Talent, including work email, phone, and LinkedIn data when available.
Josh Thornton holds Bachelor Of Science (B.S.), Business, Management, Marketing, And Related Support Services from West Chester University Of Pennsylvania.
Josh Thornton is listed with skills including Inbound Marketing, Seo, Link Building, Web Development, and Small Business Solutions.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts